Promiliad Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 3

Promiliad General Information

Description

Developer of a drug discovery platform designed to focus on the development of new antibacterial and antifungal agents. The company's platform uses a technology called ReBACS which offers a complex and rich structural diversity, enabling scientists to simplify the synthetic challenge in drug discovery and increasing the probability of generating new lead compounds.

Contact Information

Website
www.promiliad.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 950 West Fork Petty Creek Road
  • Alberton, MT 59820
  • United States
+1 (406)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 950 West Fork Petty Creek Road
  • Alberton, MT 59820
  • United States
+1 (406)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Promiliad Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Grant 01-Sep-2020 $1.5M Completed Generating Revenue
10. Grant 04-Apr-2019 Completed Generating Revenue
9. Grant 01-Sep-2018 Completed Generating Revenue
8. Later Stage VC Completed Generating Revenue
7. Grant 15-Jul-2016 Completed Generating Revenue
6. Grant 01-Jul-2013 Completed Generating Revenue
5. Grant 01-Jul-2011 Completed Generating Revenue
4. Grant 15-Jul-2009 Completed Generating Revenue
3. Grant 01-Jan-2006 $2.56M Completed Startup
2. Grant 15-Jul-2005 $474K Completed Startup
To view Promiliad’s complete valuation and funding history, request access »

Promiliad Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Promiliad Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9382213-B2 Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase Inactive 12-Feb-2014
US-20150225353-A1 Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase Active 12-Feb-2014

Promiliad Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Promiliad Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute Of Allergy and Infectious Diseases Government
TechGROWTH Ohio Not-For-Profit Venture Capital Minority
U.S. Department of Health and Human Services Government
To view Promiliad’s complete investors history, request access »

Ready to get started?

Request a free trial

Promiliad FAQs

  • When was Promiliad founded?

    Promiliad was founded in 2002.

  • Where is Promiliad headquartered?

    Promiliad is headquartered in Alberton, MT.

  • What is the size of Promiliad?

    Promiliad has 6 total employees.

  • What industry is Promiliad in?

    Promiliad’s primary industry is Drug Discovery.

  • Is Promiliad a private or public company?

    Promiliad is a Private company.

  • What is Promiliad’s current revenue?

    The current revenue for Promiliad is .

  • Who are Promiliad’s investors?

    National Institute Of Allergy and Infectious Diseases, TechGROWTH Ohio, and U.S. Department of Health and Human Services have invested in Promiliad.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »